Finally, Doyle Wealth Management bought a new position in Cvs Health Corporation during the first quarter valued at approximately $208,000.
If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation.
Citigroup Inc. dropped their price objective on shares of CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Thursday.
Jefferies Group LLC restated a “hold” rating and set a $82.00 target price on shares of CVS Health Corporation in a research report on Friday, June 9th.
Robert W. Baird restated an “outperform” rating and set a $90.00 target price on shares of CVS Health Corporation in a research report on Monday, August 14th.
- CVS Health Corporation (CVS) Shares Bought by Rothschild Investment Corp ILHi-tech Beacon
- Haverford Financial Services Inc. Has $8.73 Million Position in CVS Health ...Markets Daily
- CVS Health Corporation (CVS) Director Richard J. Swift Sells 2500 Shares of StockTrueBlueTribune
- CVS Health Corporation (CVS) Stake Reduced by Haverford Trust Co.StockNewsTimes
- CVS Health Corporation - Receive News & Ratings DailyBBNS
- CVS Health Corporation (NYSE:CVS) Shares Sold by Main Street Research LLCAppsforPCdaily
- Gofen & Glossberg Trimmed Cvs Health (CVS) Position as Stock Value Declined ...BZ Weekly
- CVS Health Corporation (NYSE:CVS) Stake Cut by Texas Permanent School FundNewburgh Gazette
- Why Investors remained confident on CVS Health Corporation (CVS), CytRx ...StockNewsJournal